Conversations As Medicine Compassion-Based Difficult Conversations

Similar documents
Practical Tools to Successfully Taper Prescription Opioids. Melissa Weimer, DO, MCR

Difficult Conversations

2/7/2017. Avoid compassion traps. Avoid All or Nothing Traps. Some Explanatory Models of Addiction

ten questions you might have about tapering (and room for your own) an informational booklet for opioid pain treatment

MANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER Melissa B. Weimer, DO, MCR Chief of Behavioral Health & Addiction Medicine St.

Principles and language suggestions for talking with patients

The science of the mind: investigating mental health Treating addiction

7/7/2016 Journal of the American Medical Association,

Background Information, FAQs, and Having Difficult Conversations with Patients

Trauma-Informed Difficult Conversations: building capacity for resilient clinical relationships

CDC Guideline for Prescribing Opioids for Chronic Pain. Centers for Disease Control and Prevention National Center for Injury Prevention and Control

Motivational Interviewing

Screening, Identification, Counseling, and Treatment of Opioid Use Disorder

Six Building Blocks Self-Assessment Questionnaire Workshop Version July 2017

Buprenorphine 2.0: I have my waiver, now what? Dr. Ritu Bhatnagar, M.D., M.P.H. Dr. John Ewing, M.D., FASAM. Disclosures

My Spouse is Addicted to Xanax, What Do I Do?

Project Nurture Collaborative. Alison Noice, MA CADC-III Christy Hall Helen Bellanca, MD, MPH

Interdisciplinary Management of Opioid Use Disorder in Rural Primary Care Settings

Medication-Assisted Treatment. What Is It and Why Do We Use It?

AFSP SURVIVOR OUTREACH PROGRAM VOLUNTEER TRAINING HANDOUT

Subject: Pain Management (Page 1 of 7)

Addressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention

Opioid Dependence and Buprenorphine Management

Opiate Use Disorder and Opiate Overdose

New Guidelines for Opioid Prescribing

DURING A SUICIDAL CRISIS

MANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER

SAFE PRESCRIBING: RULES AND REGULATIONS. Michelle Y. Owens, MD MS State Board of Medical Licensure June 30, 2017

1) To understand the scope of the opioid epidemic with relation to Emergency Departments 2) To gain insight into some emerging Emergency Medicine

Patient and Family Agreement on Opioids

6/27/2017. Disclosures. Overview. Case Overview

Problem Situation Form for Parents

What Is Heroin? Examples of Opioids. What Science Says about Opioid Use Disorder and Its Treatment 6/27/2016

Controlled Substance and Wellness Agreement

Operation S.A.V.E Campus Edition

Welcome - we will begin the webinar shortly Please read the participation tips below:

Motivational Interviewing in Healthcare. Presented by: Christy Dauner, OTR

Prescribing drugs of dependence in general practice, Part C

NALTREXONE DAVID CRABTREE, MD, MPH UNIVERSITY OF UTAH HEALTH, 2018

Methadone Maintenance 101

We admitted that we were powerless over alcohol that our lives had become unmanageable.

Trigger. Myths About the Use of Medication in Recovery BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS

Is there any way you might be better off if you quit? What happens when you think about it? What do you imagine will happen if you don t change?

Supporting Recovery: The Role of the Family

We admitted that we were powerless over alcohol that our lives had become unmanageable. Alcoholics Anonymous (AA) (2001, p. 59)

New Guidelines for Prescribing Opioids for Chronic Pain

Compassion Resilience. Sue McKenzie WISE and Rogers InHealth

Universal Precautions and Opioid Risk. Assessment. Questions: How often do you screen your patients for risk of misuse when prescribing opioids?

Motivational Strategies for Challenging Situations

Opioid Tapering and Withdrawal Guidance

Today the overuse of opioids is a problem. Many of

OUD & MAR: Caring for Our Communities

D. Janene Holladay, M.D. Board Certifications: American Board of Anesthesiology American Board of Pain Medicine American Board of Addiction Medicine

Breaking Down Barriers and Creating Partnership in Diabetes Self-Management

Welcome to the Opioid Overdose Prevention Project

ROLE PLAY #1: ASSESSMENT WITH THE 6 A s PATIENT ROLE

Get Help Now. Call us INTERVENTION GUIDE

Opioid Prescribing for Acute Pain

Respect Handout. You receive respect when you show others respect regardless of how they treat you.

A Helping Model of Problem Solving

Medication Assisted Treatment. Nicole Gastala, MD

William H. Swiggart, MS

QUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D.

Overdose Prevention: Empowering School Personnel & Families

the facts about BUPRENORPHINE for Treatment of Opioid Addiction

USING ASSERTIVENESS TO COMMUNICATE ABOUT SEX

Session 1: Days 1-3. Session 4: Days Session 2: Days 4-7. Session 5: Days Session 3: Days Day 21: Quit Day!

Homework Tracking Notes

some things you should know about opioids before starting a prescription an informational booklet for opioid pain treatment

Opioid Use Disorder Treatment: Buprenorphine Treatment Basics

Prescription Drug Safety for Teens

The CARA & Buprenorphine Prescribing for APNs & PAs

Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT)

When I m Angry. Presented by: Diane Wagenhals, M.Ed., CFLE Website:

MOTIVATION FOR CHANGE: OVERCOMING HELPLESSNESS

Treatment of Acute on Chronic Pain. Mark M. Passey, MD

Choosing Life: Empowerment, Action, Results! CLEAR Menu Sessions. Substance Use Risk 5: Drugs, Alcohol, and HIV

HARM REDUCTION & TREATMENT. Devin Reaves MSW

Screening Brief Intervention and Referral for Treatment (SBIRT) for Substance Use: A Simple, Effective Method for Intervention

Tuscarawas County Health Department. Vivitrol Treatment Consent

Report to The Vermont Legislature. Substance Abuse Treatment Services Objectives and Performance Measures Progress: Second Annual Report

Understanding Medication in Addiction Treatment for Drug Court Participants

K I N G. mentally ill E N. 38 myevt.com exceptional veterinary team March/April 2012

OPIOID USE DISORDER AND THE PSYCHIATRIC EMERGENCY ROOM THE VA CT MODEL

Linking Opioid Treatment in Primary Care. Roxanne Lewin M.D.

Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT)

Changing Course: statewide efforts to combat the opioid epidemic in California

Welcome to Motivational Interviewing Enhancing Motivation to Change Strategies. This is the third module that you ll be taking about motivational

Opioid Overdose in Oregon

Treatment of Pain in an Emergent Setting

Taste of MI: The Listener. Taste of MI: The Speaker 10/30/2015. What is Motivational Interviewing? (A Beginning Definition) What s it for?

Youth Detox & Supported Recovery Annual Program Report

Methadone and Naltrexone ER

Your Child s Treatment Roadmap

Ken Roy, MD, FASAM. The Opioid Epidemic and Addiction Involving the Use of Opioids. Tulane & LSU Department of Psychiatry

Hope for Families Helping Parents Address Teen/Young Adult Substance Use. Patricia Aussem, LPC, MAC Partnership for Drug-Free Kids Consultant

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

Why do i need to watch for suicide?

The Challenging Patient with Chronic Opioid Usage MD ACP Meeting

Transcription:

Conversations As Medicine Compassion-Based Difficult Conversations October 27, 2016 Laura Heesacker, LCSW Behavioral Health Innovation Specialist And Jim Shames, MD Public Health Officer Jackson County

Acknowledgements Jackson Care Connect-Laura Health and Human Services Ja. Co.-Jim Oregon Pain Guidance Oregon-Prescription Drug Overdose Grant No Financial Conflicts of Interest

Objectives Understand the steps necessary to plan a successful opioid taper Offer 5 Navigation Strategies to ease the course with potentially challenging patient conversations. Describe several opioid taper case scenarios Provide opportunities to practice compassion-based conversations

How to approach an opioid taper/cessation Indication for Taper Recommended Length of Taper Degree of Shared Decision Making about Taper Intervention/Setting Substance Use Disorder No taper, immediate referral None provider choice alone Intervention: Transition to medication assisted treatment (MAT, ie. buprenorphine or methadone) for OUD, Naloxone rescue kit Setting: Detox, inpatient or outpatient treatment with MAT Diversion No taper to rapid taper (days) None provider choice alone Determine need based on actual use of opioids, if any At risk for severe harms Weeks Moderate provider led & patient views sought Intervention: Supportive care Naloxone rescue kit Setting: Outpatient opioid taper or inpatient withdrawal management Option: Buprenorphine (OBOT) Therapeutic failure Months to year Moderate provider led & patient views sought Intervention: Supportive care Naloxone rescue kit Setting: Outpatient opioid taper Option: Buprenorphine (OBOT) At risk for less severe harms Months to Years Moderate provider led & patient views sought Intervention: Supportive care Naloxone rescue kit Setting: Outpatient opioid taper Option: Buprenorphine (OBOT)

Outpatient Tapering Options Gradual taper: 5-10% decreases of the original dose every 5-28 days Once 30% of the original dose is reached, then decrease each taper step by 10% of the remaining dose every 5-28 days You may elect to taper Extended release (ER) or Immediate release (IR) first generally taper ER first and use IR for breakthrough pain Provide the patient a copy of the taper plan for reference and to help keep patient moving forward Resource: Courtesy of Melissa Weimer, DO, MCR 5

Outpatient Tapering Options Rapid taper: Daily to every other day reductions over 1-2 weeks as appropriate Medication assisted taper: Adjuvant opioid withdrawal medications only Office based buprenorphine withdrawal assistance (i.e. detox) or maintenance transition Referral for Methadone maintenance treatment Resource: Courtesy of Melissa Weimer, DO, MCR 6

Medication Assisted Treatment Some patients will be unable or intolerant of taper Methadone >30mg MED >200mg Long term use > 5 years Mental illness, history of adverse childhood experiences (ACEs), history of substance use disorder, poor social supports Buprenorphine/naloxone is an important resource for these patients Interdisciplinary pain programs +/- MAT have good outcomes Huffman, et al. Opioid use 12 months following interdisciplinary pain rehab with weaning. Pain Med 2013; 14 (12):1908-1917. Resource: Courtesy of Melissa Weimer, DO, MCR

Case: Substance Use Disorder 50 yo male prescribed hydromorphone 4mg every 3 hours and fentanyl 50mcg patch for chronic pancreatitis. You detect alcohol on a routine urine drug screening, and he admits that he has relapsed on alcohol. What do you do? Decide that the risks greatly outweigh the benefit Refer for detoxification from alcohol and opioids Stop prescribing opioids immediately Consider buprenorphine/naloxone, if alcohol abstinent Resource: Courtesy of Melissa Weimer, DO, MCR

Case: Suspect Diversion 28 yo female prescribed opioids for chronic abdominal pain. She states she has lost her opioid prescription for the third time. She has had two negative urine drug tests for the opioid that is prescribed and refuses to come in for a pill count. You suspect diversion. Check PDMP Taper Plan: None. You stop prescribing opioids immediately. Resource: Courtesy of Melissa Weimer, DO, MCR

Case: At Risk for Severe for Severe Harms 50 yo man on opioids for LBP x 5 years is prescribed fentanyl 75mcg/72 hours. Hospitalized for bowel obstruction. Hx of falls Hx of depression Resource: Courtesy of Melissa Weimer, DO, MCR

Case: Lost Generation Legitamate Pain, Compliant, w/ therapeutic alliance 68 yo female with rheumatoid arthritis pain. She is prescribed a total of 350mg MED for the last 5 years with no adverse events. She is moderately functional. Your clinic has developed a new opioid policy stating that patients prescribed doses >120mg MED need to attempt an opioid taper. She is concerned that she might develop serious harms from her opioids. Taper plan: Slow taper by 10% per month over a year to a safer dose. May elect to slow down the taper if she experiences periods of worsening pain and/or opioid withdrawal. If her disease continues to generate active nociceptive pain not controlled with DMARDs, she may well be a candidate for long-term opioids, but at a safer dose. Resource: Courtesy of Melissa Weimer, DO, MCR

Case: Lost Generation with Hopelessness 63 yo man with history of low back pain and severe depression after a work injury in 1982. He has not worked since and spends most of his day being sedentary. He has been unwilling to engage in additional pain modalities despite multiple offers. He is prescribed oxycodone IR 30mg every 4 hours. You have tried other opioids but he has not had improvements. He refuses an opioid taper and states he will seek another provider if you start to taper his opioids. Taper Plan: Offer buprenorphine, subacute detox program, OR a 1 month rapid opioid taper Resource: Courtesy of Melissa Weimer, DO, MCR

Gripe and Treasure Hunt!

Listening and Validation vs. Problem Solving Listening is Doing Something The opium haze gradually draws back. It becomes less like an intervening barrier and more and more like an aura emanating from the patient. Seeing the Patient Through an Opium Haze Balint Groups-2016 John Muench, MD, MPH Dept of Family Medicine-OHSU

Difficult Conversations in Medicine? Antibiotics End of life-hospice Stimulants Hypnotics Benzodiazepines Opioid refusal for CNNP Opioid taper Opioid removal based on risk/aberrant behavior

Being with suffering and feeling helpless Reduced Patient satisfaction Conversations take more time Not enough team support Not enough effective non-opioid tx options Pt won t agree to non-opioid tx When you buy the science (I don t believe it) Discomfort with expressed emotions/guilt/shame Disbelief that my patient is misusing/abusing (The place where it hurts is the place where you care)

Are all Patients Resistant to Change? Power of 1/3rds-(Receptive, Ambivalent, Resistant)-M. Parchman-Group Health (2016) and anecdotal experience 1 in 4 patients receiving long-term opioid therapy in a primary care setting struggles with opioid-cdc 1 in 10 are deliberately using in a way that might result in harm-kevin E. Vowles, U of NM

5 Step Navigation Process Courtesy of Barry Egener, MD 1. Navigating the emotional landscape 2. Elicit the Patient s Perspective 3. Present your perspective 4. Agree on common goals 5. Set Limits

Navigating the Emotional Landscape- Step 1 of 5 1. Awareness of Common Traps and Negotiation Strategies 2. Deal with Emotions (Model willingness, Reflect, Validate, Support,) 3. Drop Defensiveness 4. Share Control when Safety Allows 5. Focus on Function, not Pain 6. Agree to Disagree (identify the impasse, clarify boundaries, manage your reactions, learn to soothe self)

Traps and Levels of Negotiation References: courtesy of Brad Anderson, MD Keiser-Portland

Given all that I have been through you just want me to suffer? (Compassion Trap)

If you cut me off I will loose my job and become homeless! (All or Nothing Trap)

Are you accusing me of being an addict? (Addiction Labeling/Guilt Trap)

Don t bother with any other meds, I ll just kill myself. (Desperate/Threatening Trap)

Negotiation Strategies/Trap Trauma Drama-fast talking Intimidation Inconsolable crying

Navigating the Emotional Landscape- Step #1 Team Practice Identifying Traps/Negotiations Generate Examples of Traps from Own Practice Team A-Bobcats Team B-Tiger Cubs Team C-Wolfs Team D- Bears Be Ready to Report out

Navigating the Emotional Landscape- Step #1 1. Deal With Emotions 2. Don t Be Defensive 3. Share Control 4. Focus On Function, Not Pain

Navigating the Emotional Landscape- Step #1 Dealing With Emotions (yours and your Pt s) Support Validation Willingness to feel uncomfortable Reflection

Navigating the Emotional Landscape- Step #1 Willingness to Feel Uncomfortable Parallel Process Neither one of us could stand to be with the horrific emotional pain she lived with everyday!

The Art and Science of Compassion The parallel process of the patients and providers is.both brains take the low road Resource: Courtesy of Kim Swanson, Ph.D.-St. Charles Health System, Bend, OR

Navigating the Emotional Landscape- Step #1 REFLECTION You seem upset by what I ve said. You seem pretty angry. I notice you are tearing up Your body language looks tense to me

Navigating the Emotional Landscape- Step #1 Validation Anyone would be upset if they had to deal with pain 24 hrs a day. All pain is real I can understand that you might be angry with me for not prescribing narcotics when that s the main reason you came in today. I m sure it s been difficult to keep going to the doctor and to repeatedly have these tugs of war about a prescription. YOU DON T HAVE TO AGREE TO EXPRESS UNDERSTANDING!

Navigating the Emotional Landscape- Step #1 SUPPORT I will have my MA call you tomorrow just to check in I won t abandon you as your provider We are here for you I care about you Or, for example, instead of speaking, Hand a crying patient a tissue.

Navigating the Emotional Landscape- Step #1 Triad Practice: Tools=Willingness to feel uncomfortable, Reflection, validation, and Support Divide into groups of three Person A=Patient-uses traps/negotiations in an attempt to get needs met Person B-Provider-uses tools above Person C-Scribe-keep time, jot down observations, provide feedback But 1 st -lets see it in action!

Navigating the Emotional Landscape- Step #1 1. Deal With Emotions 2. Don t Be Defensive 3. Share Control 4. Focus On Function, Not Pain

Navigating the Emotional Landscape- Step #1 Don t Be Defensive Defensiveness Escalates Emotion Instead, make a statement about the patient s experience I am sorry for your loss

Navigating the Emotional Landscape- Step #1 Share Control (when it is safe) Models Collaboration Avoids Backing Patient into Corner Empowers the Patient to Make Changes Higher risk lower shared decision making (M.Weimer chart)

Navigating the Emotional Landscape- Step #1 Focus on Function Permits progress despite ongoing pain What can the patient do? What do the symptoms prevent?

Navigating the Emotional Landscape- Step #1 Triad Practice: Tools= Non-Defensiveness, Sharing Control, and Focus on Function Divide into groups of three Person A=Patient-uses traps/negotiations in an attempt to get needs met Person B-Provider-uses tools above Person C-Scribe-keep time, jot down observations, provide feedback But 1 st -lets see it in action!

Navigating the Emotional Landscape- Step #1 Agreeing to Disagree (When Provider and Patient Can t Agree) Identify the impasse Clarify boundaries Manage your reactions Learn to Soothe yourself

Navigating the Emotional Landscape- Step #1 Identify the Impasse It seems like we have reached an impasse. You and I have very different views on how best to manage your pain.

Navigating the Emotional Landscape- Step #1 Clarify Boundaries What you will do: I d like to be your doctor and continue to help you with your help, despite our disagreement. What you will not do: Prescribing more of this medicine is something that is not in your best long-term interest. It is something that I feel uncomfortable with and cannot do.

Navigating the Emotional Landscape- Step #1 Manage Your Reactions When you say No What do you feel? What thoughts do you have?

Navigating the Emotional Landscape- Breathe Step #1 Learn to Soothe Yourself Create a Mantra- I can do this with compassion and grace Self-talk: I m being a helpful doctor. I can get through this.

Navigating the Emotional Landscape- Step #1 Triad Practice: Tools= Agreeing to Disagree: Identify the Impasse, Clarify Boundaries, Manage your Reactions, Learn to Soothe Self Divide into groups of three Person A=Patient-uses traps/negotiations in an attempt to get needs met Person B-Provider-uses tools above Person C-Scribe-keep time, jot down observations, provide feedback But 1 st -lets see it in action!

Navigating the Emotional Landscape- Step #1 Team Practice Responding to Traps/Negotiations Generate Example Responses based on tools from Step 1: Team A-Bobcats Team B-Tiger Cubs Team C-Wolfs Team D- Bears Be Ready to Report out

Navigating the Emotional Landscape- Step #1 Triad Practice: Tool= All of them Divide into groups of three Person A=Patient-Goal: to get provider to give them the key Person B-Provider-Goal: Compassionately Refuse to Give up the Key Person C-Scribe-keep time, jot down observations, provide feedback

Elicit the Patient s Perspective Step 2 Help the patient describe: The nature of the problem and how the problem has affected him/her Beliefs about causation Concerns about consequences of pain/ the future Expectations: Exactly what help the patient wants DON T ASSUME YOU KNOW!

Present Your Perspective -Step #3 Create an Empathic Bridge Present Your Perspective Conflict resolution in the face of anger: Assent Consolation Apology 2 Min. Elevator Speech (ask what pt heard)

The Art and Science of Compassion Start the conversation the right way. Your 1 minute elevator speech: "Recent research has demonstrated that the use of opioids is proving to be less effective and less safe than we were once led to believe. In fact, there are some potentially dangerous side effects. I would like to take a few minutes to share how these new safety guidelines relate specifically to your medical treatment. References: Courtesy of Laura Heesacker, LCSW, Jackson Care Connect

Agree on Common Goals Step #4 Allows Collaboration Despite Disagreement First agree on goals, then methods Positions vs Interests

Set Limits Step #5 Frame limits professionally, not personally Concentrate on what you are willing to do, rather than on what you refuse to do

Thank You Heesackerl@Careoregon.org 7 th Annual Pain Conference in Ashland on May 4,5, and 6, 2017- Oregonpainguidence.org